Penumbra Q1 revenue $374.8M (+15.6% YoY); net income $32.6M; no guidance due to pending BSX acquisition

Penumbra Inc

2026-Q1 EPS reported $0.82 revenue$374,758,000

Revenue $374.8M, up 15.6% YoY; thrombectomy $253.9M (+12.1%), embolization & access $120.8M (+23.8%).
Gross margin 67.6% (+1.0 pp); operating income $38.2M; net income $32.6M.
Operating expenses include $9.4M acquisition-related costs for pending Boston Scientific deal.
No FY2026 guidance provided due to pending acquisition by Boston Scientific (NYSE: BSX).

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

Penumbra Inc reported first quarter ended March 31, 2026 results: revenue $374.8 million, net income $32.6 million.

Period: first quarter ended March 31, 2026
Revenue: $374.8 million
Net income: $32.6 million
Result: reported results

Exact text from the filing

Penumbra, Inc. Reports First Quarter 2026 Financial Results ALAMEDA, Calif., May 6, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the first quarter ended March 31, 2026. • Revenue of $374.8 million in the first quarter of 2026, an increase of 15.6% compared to the first quarter of 2025. • Global thrombectomy revenue of $253.9 million in the first quarter of 2026, an increase of 12.1% compared to the first quarter of 2025. • Global embolization and access revenue of $120.8 million in the first quarter of 2026, an increase of 23.8% compared to the first quarter of 2025. • Gross profit margin of 67.6% in the first quarter of 2026, an increase of 1.0% compared to the first quarter of 2025. • Total operating expenses of $215.2 million in the first quarter of 2026, comprised of R&D of $22.4 million and SG&A of $192.8 million, which includes $9.4 million of acquisition-related expenses associated with the pendin

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

Penumbra Inc filing history →

Source: SEC EDGAR

accession 0001321732-26-000018

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.